Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Off-the-shelf Natural Killer cell therapies for solid and blood cancers
NK:IO develops cancer immunotherapies based on human Natural Killer cells, harnessing the body's innate immune system as an alternative to T-cell-based approaches. The company's…
Programmable biological manufacturing of sustainable designer chemicals
Lypo is an Edinburgh-based biotechnology company developing a platform for the programmable manufacture of high-performance chemicals from sustainable and waste-derived…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core…
AI and photonics platform for personalised drug development
iLoF is a digital health company developing an AI-powered platform that uses proprietary photonics technology to generate optical fingerprints from blood samples, building a…
Oligonucleotide therapeutics designed to upregulate protein expression
Orfonyx Bio is a biotechnology company developing genetic medicines that increase, rather than silence, the expression of therapeutic target proteins. Its platform generates…
NLRP3 inflammasome inhibitors for chronic inflammatory disease
NodThera is a clinical-stage biotechnology company developing potent and selective small molecule inhibitors of the NLRP3 inflammasome for diseases driven by chronic inflammation.…
Novel small-molecule anti-fibrinolytic for acute traumatic and surgical bleeding
ClotProtect Therapeutics is a University of Leeds spin-out developing a first-in-class small molecule anti-fibrinolytic to address acute bleeding following trauma and surgery. The…
Oncolytic adenovirus therapeutics for solid tumour cancer treatment
PsiVac is a UK-based biotechnology company developing oncolytic virus therapeutics for the treatment of cancer. Its patented technology uses genetically modified adenoviruses…
Exosome-delivered gene editing therapies for neurodegenerative diseases
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies for rare, genetically driven neurodegenerative diseases. Its proprietary platform uses…
Automated chiral chemistry platform for small molecule drug discovery
LCC Technologies is a drug discovery company providing biopharma partners with access to its platform, which combines a proprietary billion-scale virtual chiral library with…
Cell-specific mRNA delivery platform for genetic medicines
Nuntius Therapeutics is a London-based biotechnology company developing mRNA therapies using proprietary peptide dendrimer and lipid-based nanocarriers designed to deliver genetic…
Oxford University spinout producing cultivated beef and pork
Ivy Farm Technologies is a company developing cultivated meat using a non-GMO cell culture process originally developed at the University of Oxford. Its Oxford pilot plant…